Multiple interconnected pathways may underlie impaired brain insulin signaling in schizophrenia. These include both central/neurobiological mechanisms (i.e., neuroinflammation, mitochondrial dysfunction, Akt pathway dysfunction, oxidative stress) and peripheral mechanisms (i.e., visceral adiposity, increased insulin release, chronic stress, and inflammation). Additionally, antipsychotic medications exacerbate both peripheral and central mechanisms, contributing to increased appetite and weight gain, increased insulin release, increased hepatic glucose production, and decreased glucose uptake by skeletal muscle.

file_download Download in HQ

Related content

What are the diagnostic challenges in schizophrenia, and how can AI-augmented psychopathology help? play_circle Video play_circle
What are the diagnostic challenges in schizophrenia, and how can AI-augmented psychopathology help?

Professor Andrea Raballo proposes that AI-driven analysis of clinical records and linguistic markers can identify subclinical patterns preceding overt symptomatology.

29.07.2026 Schizophrenia
What do you think about the role of AI in medicine? play_circle Video play_circle
What do you think about the role of AI in medicine?

In this video, Professor Andrea Raballo reflects on how AI is transforming medicine, as well as society as a whole.

29.07.2026 Schizophrenia
What would be your general recommendations for clinicians treating people with schizophrenia? play_circle Video play_circle
What would be your general recommendations for clinicians treating people with schizophrenia?

In this video, Professor Dr. Stefan Leucht outlines four recommendations for antipsychotic prescribing.

09.07.2026 Schizophrenia